The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
The requested protein is correctly identified as fruit-fly Gfat1, also known as CG12449 and zeppelin (zep), rather than a mammalian GFAT1 or the separate fly paralog Gfat2/CG1345. Fly deficiency mapping, non-complementation, mutant sequencing, and RNAi phenocopy connect zep directly to Gfat1/CG12449. This satisfies the organism and gene-identity checks required before functional interpretation. (jackson2007gfat1zeppelinisan pages 81-86, jackson2007gfat1zeppelinisan pages 39-46)
Gfat1 is a glutamine:fructose-6-phosphate amidotransferase, EC 2.6.1.16, assigned the reaction:
L-glutamine + D-fructose-6-phosphate → L-glutamate + D-glucosamine-6-phosphate.
It therefore controls entry into de novo hexosamine biosynthesis. Its product, glucosamine-6-phosphate, is processed downstream to UDP-N-acetylglucosamine (UDP-GlcNAc), which supplies insect chitin synthesis and multiple glycosylation pathways. The strongest gene-specific biological evidence is that Gfat1/zep is essential for normal cuticle and tracheal development. Direct purified-enzyme kinetics and direct protein-level subcellular-localization data for A8Y5A1 remain limited. (jackson2007gfat1zeppelinisan pages 81-86, jackson2007gfat1zeppelinisan pages 34-39, jackson2007gfat1zeppelinisan pages 23-28)
| Annotation topic | Best-supported conclusion | Evidence type/strength | Key caveat |
|---|---|---|---|
| Identity | UniProt A8Y5A1 is consistent with D. melanogaster Gfat1, the heterochromatic CG12449/zeppelin (zep) locus. Deficiency mapping, mutant sequencing, non-complementation, and RNAi phenocopy support this identification. (jackson2007gfat1zeppelinisan pages 81-86, jackson2007gfat1zeppelinisan pages 39-46) | Strong, direct fly genetics | Historical records also contain CG40197 and varying cytogenetic assignments; these aliases do not indicate another protein. (jackson2007gfat1zeppelinisan pages 23-28, jackson2007gfat1zeppelinisan pages 28-33) |
| Reaction, substrates, and products | GFAT1 is assigned EC 2.6.1.16: L-glutamine + D-fructose-6-phosphate → L-glutamate + D-glucosamine-6-phosphate. Its glutaminase module releases ammonia, which is transferred internally to the sugar-isomerase module for fructose-6-phosphate amination and isomerization. (jackson2007gfat1zeppelinisan pages 34-39) | Strong conserved-mechanism inference; limited purified fly-enzyme evidence | The reaction is well established for the GFAT/GlmS family, but fly-specific kinetic constants and alternative-substrate measurements were not found. |
| Domains and architecture | The predicted fly protein is a two-module GFAT: an N-terminal glutaminase/Ntn-hydrolase region and a C-terminal sugar-isomerase region containing SIS-related architecture; one analysis placed these approximately at residues 1–307 and 317–637. Conserved catalytic-region mutations cause severe fly phenotypes. (jackson2007gfat1zeppelinisan pages 81-86, jackson2007gfat1zeppelinisan pages 34-39) | Strong sequence/evolutionary inference plus genetic support | Exact UniProt/InterPro boundaries can differ from historical residue assignments; a fly experimental structure was not identified. |
| Intracellular localization | GFAT1 most plausibly functions as a soluble intracellular enzyme, where cytosolic fructose-6-phosphate and glutamine enter the hexosamine biosynthetic pathway. | Moderate inference from substrates, pathway, and conserved GFAT biology | No direct fly immunolocalization or fractionation study establishing cytosolic localization was found; developmental tissue expression is not subcellular localization. |
| HBP and UDP-GlcNAc output | GFAT1 catalyzes the entry/committed step of de novo hexosamine synthesis. Glucosamine-6-phosphate is subsequently converted to UDP-GlcNAc, supporting glycoprotein/glycolipid glycosylation, O-GlcNAcylation, and—in insects—chitin synthesis. UDP-GlcNAc strongly inhibited expressed fly GFAT1 activity in a cell-free yeast assay. (jackson2007gfat1zeppelinisan pages 34-39, jackson2007gfat1zeppelinisan pages 23-28) | Strong pathway assignment; moderate fly-specific regulatory evidence | GFAT1 does not itself synthesize UDP-GlcNAc, and direct metabolomic flux measurements specific to Gfat1 were not found. |
| Development, cuticle, and chitin | Gfat1/zep is essential. Loss-of-function alleles and RNAi cause defective embryonic/procuticle formation, abnormal expandable “blimp” embryos, splayed adults, melanotic leg-joint lesions, failed eclosion, and lethality, consistent with inadequate glucosamine-6-phosphate and chitin deposition. (jackson2007gfat1zeppelinisan pages 81-86, jackson2007gfat1zeppelinisan pages 86-91, jackson2007gfat1zeppelinisan pages 39-46) | Strong, direct fly genetic and phenotypic evidence | Chitin or pathway-metabolite abundance was not quantified in the cited historical study, so the biochemical link is compelling but partly mechanistic inference. |
| Tissue and developmental expression | Transcripts were reported in stage-16 embryonic tracheae, broadly in the stage-17 epidermis/cuticle, in late-third-instar salivary-gland corpus cells, and during pupation—sites consistent with tracheal/cuticular chitin production and glue-protein glycosylation. (jackson2007gfat1zeppelinisan pages 34-39, jackson2007gfat1zeppelinisan pages 71-73) | Moderate, direct expression evidence | These data identify expressing tissues, not the protein’s subcellular compartment or the quantitative contribution of Gfat1 relative to Gfat2. |
| Distinction from Gfat2 | D. melanogaster has a separate euchromatic paralog, gfat2/CG1345. The proteins are highly similar, but deletion of either gene is lethal; reports conflict on functional interchangeability, with reciprocal transgenic rescue in one analysis but differential dietary rescue in another. (oliveira2023frommetabolismto pages 5-7, jackson2007gfat1zeppelinisan pages 28-33) | Strong paralog identity; mixed functional evidence | Intestinal stem-cell proliferation and dietary GlcNAc rescue experiments chiefly tested Gfat2 and must not be attributed to Gfat1. (mattila2018stemcellintrinsic pages 4-5, mattila2018stemcellintrinsic pages 13-14) |
| Circadian and feeding evidence | Whole-body gfat1 mRNA was not detectably rhythmic under natural feeding, mistimed feeding, or in per⁰ flies (RAIN p=0.73, 0.59, and 0.76). Gfat2 transcript abundance was 5–10-fold higher, while rhythmic total GFAT activity was not isoform-specific. (liu2021hexosaminebiosyntheticpathway pages 3-5, liu2021hexosaminebiosyntheticpathway pages 5-7) | Strong direct negative evidence for gfat1 transcript rhythmicity | Rhythmic total GFAT activity, UDP-GlcNAc, or O-GlcNAcylation cannot be assigned specifically to Gfat1; available results instead implicate Gfat2 more strongly at whole-body scale. |
| Applications and experimental utility | Gfat1 is useful as a fly model for connecting nutrient flux to amino-sugar production, glycosylation, extracellular chitinous structures, heterochromatic-gene regulation, and essential development. Conserved GFAT enzymes are also being evaluated as antimicrobial, insect-control, metabolic-disease, and anticancer targets. (oliveira2023frommetabolismto pages 5-7, jackson2007gfat1zeppelinisan pages 39-46) | Established model-organism utility; translational applications are largely conceptual | No approved application or Gfat1-selective fly inhibitor was identified; paralog conservation, essentiality, and potential toxicity complicate selective targeting. |
Table: Evidence-graded functional annotation of Drosophila Gfat1, explicitly separating direct fly results from conserved-family inference and from findings that principally concern the Gfat2 paralog.
The evidence supports the following identity:
The zep locus was mapped genetically to chromosome-3 heterochromatin. Absence of the coding sequence in relevant deletions, point mutations in Gfat1 among EMS-derived zep alleles, genetic non-complementation, and RNAi reproduction of characteristic phenotypes collectively provide strong locus-level identification. (jackson2007gfat1zeppelinisan pages 81-86, jackson2007gfat1zeppelinisan pages 86-91, jackson2007gfat1zeppelinisan pages 39-46)
Historical sources disagree on the exact heterochromatic subdivision—assignments include h54–h55 and h58—but this cytogenetic uncertainty does not undermine the molecular identification as CG12449. The reported gene spans approximately 7.36 kb, contains ten exons, and was predicted historically to generate six splice transcripts. (jackson2007gfat1zeppelinisan pages 23-28, jackson2007gfat1zeppelinisan pages 28-33)
The fly genome also encodes Gfat2/CG1345, a euchromatic paralog. The predicted Gfat1 protein is 694 amino acids long and was reported to share approximately 81% homology with fly Gfat2 and 62% with human GFAT1. Consequently, papers reporting “GFAT activity” or hexosamine-pathway phenotypes cannot automatically be attributed to A8Y5A1. (jackson2007gfat1zeppelinisan pages 28-33)
Deletion of either fly gene is lethal, but evidence about interchangeability is mixed. One analysis reported reciprocal transgenic rescue, whereas another found dietary hexosamine rescue of gfat2 deficiency but not gfat1 deficiency. The suggestion that Gfat1 might make an additional noncanonical product remains speculative, not an established biochemical property. (oliveira2023frommetabolismto pages 5-7)
GFAT enzymes couple two chemical operations. The N-terminal glutaminase module hydrolyzes L-glutamine to glutamate and ammonia. The ammonia is transferred to the C-terminal sugar-processing module, where fructose-6-phosphate undergoes amination and isomerization through a fructosamine-6-phosphate intermediate to form glucosamine-6-phosphate. (jackson2007gfat1zeppelinisan pages 34-39)
Thus, the best-supported physiological substrates are:
The principal products are L-glutamate and D-glucosamine-6-phosphate. This reaction and specificity are strongly supported by conserved GFAT/GlmS-family biochemistry, but fly-specific values for Km, kcat, substrate competition, or alternative nitrogen donors were not identified. The annotation should therefore be treated as a highly reliable conserved-function assignment rather than a complete kinetic characterization of purified A8Y5A1.
GFAT is conventionally described as the committed, rate-limiting entry enzyme of the hexosamine biosynthetic pathway. UDP-GlcNAc, the pathway’s terminal nucleotide sugar, provides feedback inhibition. In a heterologous cell-free yeast assay of fly Gfat1, cAMP/PKA-associated signaling increased activity about 1.7-fold, whereas UDP-GlcNAc produced nearly complete repression and overrode cAMP stimulation. These data support regulation of fly Gfat1 but do not substitute for purified-protein kinetics in native fly cells. (jackson2007gfat1zeppelinisan pages 34-39)
A 2023 GFAT review likewise concludes that fly Gfat1 is inhibited by UDP-GlcNAc and stimulated by PKA during development. More generally, contemporary GFAT research views feedback inhibition and phosphorylation-dependent interdomain communication as major control mechanisms, although mechanistic structural work has chiefly used human or nematode GFAT-1 and should not be presented as direct evidence for A8Y5A1. (oliveira2023frommetabolismto pages 5-7)
The supplied InterPro annotations—GFAT, GlmS/AgaS-SIS, GlmS/FrlB-SIS, N-terminal nucleophile-hydrolase-related region, and SIS domains—fit the literature’s two-module GFAT architecture. A historical fly analysis assigned approximately residues 1–307 to the glutaminase region and 317–637 to the isomerase region, with a connecting hinge. Gfat1 reportedly contains 23 more hinge-region residues than Gfat2. (jackson2007gfat1zeppelinisan pages 34-39, jackson2007gfat1zeppelinisan pages 28-33)
Mutant genetics reinforce the functional relevance of this architecture. A Leu588Met allele lies near a conserved histidine loop implicated in opening the fructose-6-phosphate ring, another mutation affects a conserved cysteine important for enzyme integrity, and a truncating allele removes part of the isomerase domain. Molecular lesion severity correlates with developmental phenotype severity. (jackson2007gfat1zeppelinisan pages 81-86, jackson2007gfat1zeppelinisan pages 86-91)
A homodimeric state has been proposed from GFAT-family comparisons and genetic complementation behavior. However, no experimental fly A8Y5A1 structure or direct oligomerization measurement was identified, so dimerization should remain a conserved-family inference rather than a demonstrated fly-specific fact. (jackson2007gfat1zeppelinisan pages 81-86, jackson2007gfat1zeppelinisan pages 34-39)
Gfat1 diverts glycolytic fructose-6-phosphate into the hexosamine biosynthetic pathway. Glucosamine-6-phosphate is subsequently acetylated, isomerized, and activated to form UDP-GlcNAc. GFAT itself does not synthesize UDP-GlcNAc; it controls precursor entry into the pathway. General estimates suggest that roughly 2–5% of glucose flux enters hexosamine biosynthesis, but this is not a Gfat1-specific measurement in flies. (jackson2007gfat1zeppelinisan pages 23-28)
UDP-GlcNAc supports several downstream processes:
Accordingly, Gfat1 is best understood as a metabolic gatekeeper coupling glucose and glutamine availability to amino-sugar production rather than as a structural cuticle protein itself. (jackson2007gfat1zeppelinisan pages 34-39, jackson2007gfat1zeppelinisan pages 23-28)
The most defensible assignment is a soluble intracellular, probably cytosolic enzyme, based on its soluble substrates and conserved position at the beginning of hexosamine biosynthesis. No fly-specific immunofluorescence, tagged-protein imaging, or biochemical-fractionation experiment was found that directly establishes cytosolic localization. Tissue expression must not be mistaken for subcellular localization.
Whole-mount expression evidence places Gfat1 transcripts in:
This pattern is consistent with demand for UDP-GlcNAc during tracheal and cuticular chitin deposition and for glycosylation of salivary-gland Sgs glue proteins. Mutant pupal cases were often found at the bottom of culture vials rather than attached to the walls, consistent with altered glue-protein production or glycosylation, although this does not by itself prove a direct molecular defect in Sgs glycosylation. (jackson2007gfat1zeppelinisan pages 71-73)
The strongest direct functional evidence comes from zeppelin/Gfat1 mutants. Reduced Gfat1 function produces insufficient hexosamine-pathway precursor for normal chitinous structures, accompanied by defective or weak procuticle, abnormal expandable “blimp” embryos, splayed adult appendages, melanotic lesions at leg joints, failed eclosion, and lethality. Some mutant embryos stretched to approximately three times wild-type size, illustrating severe loss of cuticular mechanical integrity. (jackson2007gfat1zeppelinisan pages 81-86, jackson2007gfat1zeppelinisan pages 86-91)
Ten homozygous-lethal zep lesions were characterized in the historical analysis. Mutation severity correlated with three phenotypic-severity classes, and Gfat1 RNAi reproduced the splayed phenotype, strengthening causality beyond positional association. (jackson2007gfat1zeppelinisan pages 81-86, jackson2007gfat1zeppelinisan pages 39-46)
A weak transheterozygous combination yielded approximately 70% of the expected wild-type progeny. From these crosses, the original analysis inferred that pupal-to-adult development could tolerate substantial reduction in Gfat1 function until activity fell below roughly half of normal. This percentage is a genetic estimate rather than a direct enzymatic measurement. (jackson2007gfat1zeppelinisan pages 86-91)
Modern deletion evidence confirms that both gfat1 and gfat2 perform essential developmental functions. Importantly, lethality of both paralogs means that high sequence similarity does not imply that either endogenous locus is dispensable. (oliveira2023frommetabolismto pages 5-7)
The prominent Drosophila intestinal-stem-cell study concerns Gfat2, not A8Y5A1. CRISPR gfat2 null animals died as first-instar larvae and could be rescued with dietary GlcNAc. Gfat2-deficient intestinal clones showed growth and differentiation defects, whereas Gfat2 overexpression increased clone cell number and midgut mitosis. Reported statistical results included p=3.4×10⁻¹⁹ and 8.4×10⁻⁴ for clone analyses and p=0.049 for mitotic-index analysis. These findings establish the importance of hexosamine metabolism but must not be annotated as direct Gfat1 functions. (mattila2018stemcellintrinsic pages 4-5, mattila2018stemcellintrinsic pages 13-14)
A 2021 Nature Communications study showed that total fly hexosamine-pathway activity and protein O-GlcNAcylation vary with feeding and circadian organization. However, gfat1 mRNA itself was not significantly rhythmic under natural feeding, mistimed feeding, or in per⁰ mutants: RAIN p=0.73, 0.59, and 0.76, respectively. Gfat2 transcript abundance was 5–10-fold higher than gfat1 in the sampled body tissues and showed stronger feeding-associated rhythmicity. (liu2021hexosaminebiosyntheticpathway pages 3-5, liu2021hexosaminebiosyntheticpathway pages 5-7)
Total GFAT activity was rhythmic during natural feeding (p=5.73×10⁻⁷), weakly rhythmic during mistimed feeding (p=0.041), and nonrhythmic in per⁰ flies (p=0.92). Because these assays measured combined GFAT activity, the result cannot be assigned specifically to Gfat1; the expression data instead point to Gfat2 as the larger whole-body contributor in that setting. (liu2021hexosaminebiosyntheticpathway pages 5-7)
The 2024 JBC review, “Regulation of protein O-GlcNAcylation by circadian, metabolic, and cellular signals,” published February 2024, integrates this work into a broader model in which feeding rhythms, GFAT-controlled UDP-GlcNAc production, O-GlcNAc transferase, and O-GlcNAcase collectively shape daily O-GlcNAcylation. Its relevance to Gfat1 is primarily pathway-level: current evidence does not demonstrate rhythmic gfat1 transcription or a Gfat1-specific contribution to the measured O-GlcNAc rhythm.
Thus, the latest literature refines rather than overturns the annotation: A8Y5A1 is an essential developmental GFAT, but whole-animal circadian HBP regulation appears more strongly associated with Gfat2 expression or combined enzyme activity.
Drosophila Gfat1 is useful for studying:
The 2023 review “From metabolism to disease: the biological roles of glutamine:fructose-6-phosphate amidotransferase (GFAT)”, published August 2023, identifies GFAT as a candidate antimicrobial, insect-control, metabolic-disease, and anticancer target. For A8Y5A1 specifically, these are translational concepts rather than deployed applications. No approved Gfat1-selective insecticide, therapeutic, or fly-specific inhibitor was identified. (oliveira2023frommetabolismto pages 5-7)
The evidence supports a high-confidence molecular-function annotation and a high-confidence developmental role, but only a moderate-confidence subcellular-localization annotation. The most important interpretation safeguards are:
Priority experiments for improving functional annotation would include purified recombinant A8Y5A1 kinetics; isotope-resolved flux from fructose-6-phosphate into glucosamine-6-phosphate and UDP-GlcNAc; quantitative comparison with Gfat2; endogenous protein tagging and fractionation; tissue-specific rescue of null alleles; chitin and glycoproteomic measurements in gfat1 mutants; and tests of UDP-GlcNAc feedback and phosphorylation in native fly tissues.
Overall, A8Y5A1 should be annotated as an essential, intracellular GFAT-family enzyme that catalyzes the glutamine-dependent conversion of fructose-6-phosphate to glucosamine-6-phosphate, thereby supplying UDP-GlcNAc for glycosylation and especially chitin-dependent cuticle and tracheal development in D. melanogaster. The specificity of this conclusion is strongest for catalysis and developmental cuticle biology and weaker for exact subcellular localization and modern signaling phenotypes.
References
(jackson2007gfat1zeppelinisan pages 81-86): CJ Jackson. Gfat1/zeppelin is an essential heterochromatic gene involved in cuticle formation in d. melanogaster. Unknown journal, 2007.
(jackson2007gfat1zeppelinisan pages 39-46): CJ Jackson. Gfat1/zeppelin is an essential heterochromatic gene involved in cuticle formation in d. melanogaster. Unknown journal, 2007.
(jackson2007gfat1zeppelinisan pages 34-39): CJ Jackson. Gfat1/zeppelin is an essential heterochromatic gene involved in cuticle formation in d. melanogaster. Unknown journal, 2007.
(jackson2007gfat1zeppelinisan pages 23-28): CJ Jackson. Gfat1/zeppelin is an essential heterochromatic gene involved in cuticle formation in d. melanogaster. Unknown journal, 2007.
(jackson2007gfat1zeppelinisan pages 28-33): CJ Jackson. Gfat1/zeppelin is an essential heterochromatic gene involved in cuticle formation in d. melanogaster. Unknown journal, 2007.
(jackson2007gfat1zeppelinisan pages 86-91): CJ Jackson. Gfat1/zeppelin is an essential heterochromatic gene involved in cuticle formation in d. melanogaster. Unknown journal, 2007.
(jackson2007gfat1zeppelinisan pages 71-73): CJ Jackson. Gfat1/zeppelin is an essential heterochromatic gene involved in cuticle formation in d. melanogaster. Unknown journal, 2007.
(oliveira2023frommetabolismto pages 5-7): Isadora de Araújo Oliveira, Daniela Maria dos Santos Lucena, Bruno da Costa Rodrigues, Victória Trindade Maller, Rodrigo Nunes da Fonseca, Diego Allonso, and Adriane Regina Todeschini. From metabolism to disease: the biological roles of glutamine:fructose-6-phosphate amidotransferase (gfat). Pure and Applied Chemistry, 0:1009-1026, Aug 2023. URL: https://doi.org/10.1515/pac-2023-0503, doi:10.1515/pac-2023-0503. This article has 3 citations and is from a peer-reviewed journal.
(mattila2018stemcellintrinsic pages 4-5): Jaakko Mattila, Krista Kokki, Ville Hietakangas, and Michael Boutros. Stem cell intrinsic hexosamine metabolism regulates intestinal adaptation to nutrient content. Developmental Cell, 47:112-121.e3, Oct 2018. URL: https://doi.org/10.1016/j.devcel.2018.08.011, doi:10.1016/j.devcel.2018.08.011. This article has 55 citations and is from a highest quality peer-reviewed journal.
(mattila2018stemcellintrinsic pages 13-14): Jaakko Mattila, Krista Kokki, Ville Hietakangas, and Michael Boutros. Stem cell intrinsic hexosamine metabolism regulates intestinal adaptation to nutrient content. Developmental Cell, 47:112-121.e3, Oct 2018. URL: https://doi.org/10.1016/j.devcel.2018.08.011, doi:10.1016/j.devcel.2018.08.011. This article has 55 citations and is from a highest quality peer-reviewed journal.
(liu2021hexosaminebiosyntheticpathway pages 3-5): Xianhui Liu, Ivana Blaženović, Adam J. Contreras, Thu M. Pham, Christine A. Tabuloc, Ying H. Li, Jian Ji, Oliver Fiehn, and Joanna C. Chiu. Hexosamine biosynthetic pathway and o-glcnac-processing enzymes regulate daily rhythms in protein o-glcnacylation. Nature Communications, Jul 2021. URL: https://doi.org/10.1038/s41467-021-24301-7, doi:10.1038/s41467-021-24301-7. This article has 71 citations and is from a highest quality peer-reviewed journal.
(liu2021hexosaminebiosyntheticpathway pages 5-7): Xianhui Liu, Ivana Blaženović, Adam J. Contreras, Thu M. Pham, Christine A. Tabuloc, Ying H. Li, Jian Ji, Oliver Fiehn, and Joanna C. Chiu. Hexosamine biosynthetic pathway and o-glcnac-processing enzymes regulate daily rhythms in protein o-glcnacylation. Nature Communications, Jul 2021. URL: https://doi.org/10.1038/s41467-021-24301-7, doi:10.1038/s41467-021-24301-7. This article has 71 citations and is from a highest quality peer-reviewed journal.